Infinium Global Research and Consulting Solutions

The report on Global Marine-derived Drugs Market provides an in-depth analysis of segments and sub-segments in the global as well as regional marine-derived drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional marine-derived drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global marine-derived drugs market. According to the report, the global marine-derived drugs market is projected to grow at a CAGR of 11.07% over the forecast period of 2019-2025.

The report on global marine-derived drugs market covers segments such as type, source, and mode of delivery. The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2017-2025. The report provides profiles of the companies in the global Abbott Laboratories, Bayer Innovation Marine Polymer Technologies, Inc., Takeda Oncology’s Millennium, Pharma Marine USA, LLC, GlaxoSmithKline PLC, Abbvie Inc, Aker BioMarine AS, Sea Run Holdings, Inc., Aphios Corporation, and Sanofi S.A. (Sanofi Genzyme).